The EU-funded HORIZON project siNPAIN is currently holding its 5th progress meeting in Marseille, France, bringing together project partners to review milestones, share updates, and discuss the next steps in this exciting initiative.
As the regulatory partner and leader of WP6, ASPHALION has had the opportunity to present key highlights from the project. Our expert, Joan Cabellos, has provided an overview of the accomplishments achieved so far, as well as a look at the ongoing tasks. This session was followed by updates from the other project partners, who shared their progress and outlined their plans for the future.
The siNPAIN project, which aims to develop a new therapy that will combine RNA technology, nanocarriers and an improved hyaluronic acid-based knee viscosupplement (IA-HA), and is currently on its 31st month of the total 54-month project duration.
For more information about the siNPAIN project, visit the website: siNPAIN Project Website
For additional information and for all your EU-funded projects, you can also contact us at: [email protected]
